> top > docs > PubMed:20331935 > annotations

PubMed:20331935 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-134 Sentence denotes A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys.
T2 135-145 Sentence denotes OBJECTIVE:
T3 146-316 Sentence denotes The aim of the present study was to investigate the effect of risperidone-induced hyperprolactinemia on trabecular bone mineral density (BMD) in children and adolescents.
T4 317-324 Sentence denotes METHOD:
T5 325-558 Sentence denotes Medically healthy 7- to 17-year-old males chronically treated, in a naturalistic setting, with risperidone were recruited for this cross-sectional study through child psychiatry outpatient clinics between November 2005 and June 2007.
T6 559-625 Sentence denotes Anthropometric measurements and laboratory testing were conducted.
T7 626-754 Sentence denotes The clinical diagnoses were based on chart review, and developmental and treatment history was obtained from the medical record.
T8 755-947 Sentence denotes Volumetric BMD of the ultradistal radius was measured using peripheral quantitative computed tomography, and areal BMD of the lumbar spine was estimated using dual-energy x-ray absorptiometry.
T9 948-956 Sentence denotes RESULTS:
T10 957-1064 Sentence denotes Hyperprolactinemia was present in 49% of 83 boys (n = 41) treated with risperidone for a mean of 2.9 years.
T11 1065-1172 Sentence denotes Serum testosterone concentration increased with pubertal status but was not affected by hyperprolactinemia.
T12 1173-1246 Sentence denotes As expected, bone mineral content and BMD increased with sexual maturity.
T13 1247-1437 Sentence denotes After adjusting for the stage of sexual development and height and BMI z scores, serum prolactin was negatively associated with trabecular volumetric BMD at the ultradistal radius (P < .03).
T14 1438-1665 Sentence denotes Controlling for relevant covariates, we also found treatment with selective serotonin reuptake inhibitors (SSRIs) to be associated with lower trabecular BMD at the radius (P = .03) and BMD z score at the lumbar spine (P < .05).
T15 1666-1764 Sentence denotes These findings became more marked when the analysis was restricted to non-Hispanic white patients.
T16 1765-1900 Sentence denotes Of 13 documented fractures, 3 occurred after risperidone and SSRIs were started, and none occurred in patients with hyperprolactinemia.
T17 1901-1913 Sentence denotes CONCLUSIONS:
T18 1914-2045 Sentence denotes This is the first study to link risperidone-induced hyperprolactinemia and SSRI treatment to lower BMD in children and adolescents.
T19 2046-2202 Sentence denotes Future research should evaluate the longitudinal course of this adverse event to determine its temporal stability and whether a higher fracture rate ensues.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
7146 46-57 ChemicalEntity denotes risperidone MESH:D018967
7147 62-101 ChemicalEntity denotes selective serotonin reuptake inhibitors MESH:D017367
7148 208-219 ChemicalEntity denotes risperidone MESH:D018967
7149 228-246 DiseaseOrPhenotypicFeature denotes hyperprolactinemia MESH:D006966
7150 420-431 ChemicalEntity denotes risperidone MESH:D018967
7151 503-513 OrganismTaxon denotes outpatient NCBITaxon:9606
7152 957-975 DiseaseOrPhenotypicFeature denotes Hyperprolactinemia MESH:D006966
7153 1028-1039 ChemicalEntity denotes risperidone MESH:D018967
7154 1071-1083 ChemicalEntity denotes testosterone MESH:D013739
7155 1153-1171 DiseaseOrPhenotypicFeature denotes hyperprolactinemia MESH:D006966
7156 1334-1343 GeneOrGeneProduct denotes prolactin NCBIGene:5617
7157 1504-1543 ChemicalEntity denotes selective serotonin reuptake inhibitors MESH:D017367
7158 1545-1550 ChemicalEntity denotes SSRIs MESH:D017367
7159 1755-1763 OrganismTaxon denotes patients NCBITaxon:9606
7160 1782-1791 DiseaseOrPhenotypicFeature denotes fractures MESH:D050723
7161 1810-1821 ChemicalEntity denotes risperidone MESH:D018967
7162 1826-1831 ChemicalEntity denotes SSRIs MESH:D017367
7163 1867-1875 OrganismTaxon denotes patients NCBITaxon:9606
7164 1881-1899 DiseaseOrPhenotypicFeature denotes hyperprolactinemia MESH:D006966
7165 1946-1957 ChemicalEntity denotes risperidone MESH:D018967
7166 1966-1984 DiseaseOrPhenotypicFeature denotes hyperprolactinemia MESH:D006966
7167 1989-1993 ChemicalEntity denotes SSRI MESH:D017367
7168 2181-2189 DiseaseOrPhenotypicFeature denotes fracture MESH:D050723

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 228-246 DiseaseOrPhenotypicFeature denotes hyperprolactinemia 0005804
T2 957-975 DiseaseOrPhenotypicFeature denotes Hyperprolactinemia 0005804
T3 1153-1171 DiseaseOrPhenotypicFeature denotes hyperprolactinemia 0005804
T4 1881-1899 DiseaseOrPhenotypicFeature denotes hyperprolactinemia 0005804
T5 1966-1984 DiseaseOrPhenotypicFeature denotes hyperprolactinemia 0005804

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 91-101 GeneOrGeneProduct denotes inhibitors
T2 105-125 GeneOrGeneProduct denotes bone mineral density
T3 220-227 GeneOrGeneProduct denotes induced
T4 261-281 GeneOrGeneProduct denotes bone mineral density
T5 283-286 GeneOrGeneProduct denotes BMD
T6 304-315 GeneOrGeneProduct denotes adolescents
T7 317-323 GeneOrGeneProduct denotes METHOD
T8 352-356 GeneOrGeneProduct denotes year
T9 361-366 GeneOrGeneProduct denotes males
T10 388-392 GeneOrGeneProduct denotes in a
T11 548-552 GeneOrGeneProduct denotes June
T12 602-609 GeneOrGeneProduct denotes testing
T13 654-659 GeneOrGeneProduct denotes based
T14 766-769 GeneOrGeneProduct denotes BMD
T15 870-873 GeneOrGeneProduct denotes BMD
T16 888-893 GeneOrGeneProduct denotes spine
T17 1058-1063 GeneOrGeneProduct denotes years
T18 1186-1206 GeneOrGeneProduct denotes bone mineral content
T19 1211-1214 GeneOrGeneProduct denotes BMD
T20 1237-1245 GeneOrGeneProduct denotes maturity
T21 1303-1309 GeneOrGeneProduct denotes height
T22 1334-1343 GeneOrGeneProduct denotes prolactin
T23 1397-1400 GeneOrGeneProduct denotes BMD
T24 1533-1543 GeneOrGeneProduct denotes inhibitors
T25 1591-1594 GeneOrGeneProduct denotes BMD
T26 1623-1626 GeneOrGeneProduct denotes BMD
T27 1649-1654 GeneOrGeneProduct denotes spine
T28 1672-1680 GeneOrGeneProduct denotes findings
T29 1693-1699 GeneOrGeneProduct denotes marked
T30 1749-1754 GeneOrGeneProduct denotes white
T31 1765-1770 GeneOrGeneProduct denotes Of 13
T32 1837-1844 GeneOrGeneProduct denotes started
T33 1850-1854 GeneOrGeneProduct denotes none
T34 1941-1945 GeneOrGeneProduct denotes link
T35 1958-1965 GeneOrGeneProduct denotes induced
T36 2013-2016 GeneOrGeneProduct denotes BMD
T37 2033-2044 GeneOrGeneProduct denotes adolescents
T38 2127-2136 GeneOrGeneProduct denotes determine

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 91-101 GeneOrGeneProduct denotes inhibitors
T2 105-125 GeneOrGeneProduct denotes bone mineral density
T3 261-281 GeneOrGeneProduct denotes bone mineral density
T4 283-286 GeneOrGeneProduct denotes BMD
T5 304-315 GeneOrGeneProduct denotes adolescents
T6 766-769 GeneOrGeneProduct denotes BMD
T7 870-873 GeneOrGeneProduct denotes BMD
T8 888-893 GeneOrGeneProduct denotes spine
T9 1186-1206 GeneOrGeneProduct denotes bone mineral content
T10 1211-1214 GeneOrGeneProduct denotes BMD
T11 1303-1309 GeneOrGeneProduct denotes height
T12 1334-1343 GeneOrGeneProduct denotes prolactin
T13 1397-1400 GeneOrGeneProduct denotes BMD
T14 1533-1543 GeneOrGeneProduct denotes inhibitors
T15 1591-1594 GeneOrGeneProduct denotes BMD
T16 1623-1626 GeneOrGeneProduct denotes BMD
T17 1649-1654 GeneOrGeneProduct denotes spine
T18 1749-1754 GeneOrGeneProduct denotes white
T19 1850-1854 GeneOrGeneProduct denotes none
T20 1941-1945 GeneOrGeneProduct denotes link
T21 2013-2016 GeneOrGeneProduct denotes BMD
T22 2033-2044 GeneOrGeneProduct denotes adolescents

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 228-246 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T2 957-975 DiseaseOrPhenotypicFeature denotes Hyperprolactinemia D006966
T3 1153-1171 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T4 1782-1791 DiseaseOrPhenotypicFeature denotes fractures DISEASE
T5 1881-1899 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T6 1966-1984 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T7 2181-2189 DiseaseOrPhenotypicFeature denotes fracture DISEASE

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 1186-1206 GeneOrGeneProduct denotes bone mineral content
T2 1334-1343 GeneOrGeneProduct denotes prolactin
T3 1749-1754 GeneOrGeneProduct denotes white

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 228-246 DiseaseOrPhenotypicFeature denotes hyperprolactinemia 0024305|0014250|0005804
T4 283-286 DiseaseOrPhenotypicFeature denotes BMD 0010311|0007931
T6 486-491 DiseaseOrPhenotypicFeature denotes child 0017015
T7 766-769 DiseaseOrPhenotypicFeature denotes BMD 0010311|0007931
T9 870-873 DiseaseOrPhenotypicFeature denotes BMD 0010311|0007931
T11 957-975 DiseaseOrPhenotypicFeature denotes Hyperprolactinemia 0024305|0014250|0005804
T14 1153-1171 DiseaseOrPhenotypicFeature denotes hyperprolactinemia 0024305|0014250|0005804
T17 1211-1214 DiseaseOrPhenotypicFeature denotes BMD 0010311|0007931
T19 1397-1400 DiseaseOrPhenotypicFeature denotes BMD 0010311|0007931
T21 1591-1594 DiseaseOrPhenotypicFeature denotes BMD 0010311|0007931
T23 1623-1626 DiseaseOrPhenotypicFeature denotes BMD 0010311|0007931
T25 1881-1899 DiseaseOrPhenotypicFeature denotes hyperprolactinemia 0024305|0014250|0005804
T28 1966-1984 DiseaseOrPhenotypicFeature denotes hyperprolactinemia 0024305|0014250|0005804
T31 2013-2016 DiseaseOrPhenotypicFeature denotes BMD 0010311|0007931
T33 2181-2189 DiseaseOrPhenotypicFeature denotes fracture 0005315

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 228-246 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T2 957-975 DiseaseOrPhenotypicFeature denotes Hyperprolactinemia D006966
T3 1153-1171 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T4 1782-1791 DiseaseOrPhenotypicFeature denotes fractures DISEASE
T5 1881-1899 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T6 1966-1984 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T7 2181-2189 DiseaseOrPhenotypicFeature denotes fracture DISEASE

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 228-246 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T2 957-975 DiseaseOrPhenotypicFeature denotes Hyperprolactinemia D006966
T3 1153-1171 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T4 1782-1791 DiseaseOrPhenotypicFeature denotes fractures DISEASE
T5 1881-1899 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T6 1966-1984 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T7 2181-2189 DiseaseOrPhenotypicFeature denotes fracture DISEASE

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 46-57 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T3 72-81 ChemicalEntity denotes serotonin D012701|http://purl.obolibrary.org/obo/CHEBI_350546|http://purl.obolibrary.org/obo/CHEBI_28790
T6 110-117 ChemicalEntity denotes mineral D008903
T7 208-219 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T9 266-273 ChemicalEntity denotes mineral D008903
T10 420-431 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T12 1028-1039 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T14 1071-1083 ChemicalEntity denotes testosterone D013739|http://purl.obolibrary.org/obo/CHEBI_17347
T16 1191-1198 ChemicalEntity denotes mineral D008903
T17 1334-1343 ChemicalEntity denotes prolactin http://purl.obolibrary.org/obo/CHEBI_81580
T18 1514-1523 ChemicalEntity denotes serotonin D012701|http://purl.obolibrary.org/obo/CHEBI_350546|http://purl.obolibrary.org/obo/CHEBI_28790
T21 1545-1550 ChemicalEntity denotes SSRIs ChemicalEntity
T22 1810-1821 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T24 1826-1831 ChemicalEntity denotes SSRIs ChemicalEntity
T25 1946-1957 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T27 1989-1993 ChemicalEntity denotes SSRI ChemicalEntity

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 928-931 OrganismTaxon denotes ray
T2 1755-1763 OrganismTaxon denotes patients
T3 1867-1875 OrganismTaxon denotes patients

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T27 1989-1993 ChemicalEntity denotes SSRI ChemicalEntity
T25 1946-1957 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T24 1826-1831 ChemicalEntity denotes SSRIs ChemicalEntity
T22 1810-1821 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T21 1545-1550 ChemicalEntity denotes SSRIs ChemicalEntity
T18 1514-1523 ChemicalEntity denotes serotonin http://purl.obolibrary.org/obo/CHEBI_28790|http://purl.obolibrary.org/obo/CHEBI_350546|D012701
T17 1334-1343 ChemicalEntity denotes prolactin http://purl.obolibrary.org/obo/CHEBI_81580
T16 1191-1198 ChemicalEntity denotes mineral D008903
T14 1071-1083 ChemicalEntity denotes testosterone http://purl.obolibrary.org/obo/CHEBI_17347|D013739
T12 1028-1039 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T10 420-431 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T9 266-273 ChemicalEntity denotes mineral D008903
T7 208-219 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T6 110-117 ChemicalEntity denotes mineral D008903
T3 72-81 ChemicalEntity denotes serotonin http://purl.obolibrary.org/obo/CHEBI_28790|http://purl.obolibrary.org/obo/CHEBI_350546|D012701
T1 46-57 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T6833 1749-1754 GeneOrGeneProduct denotes white
T2 1334-1343 GeneOrGeneProduct denotes prolactin
T12831 1186-1206 GeneOrGeneProduct denotes bone mineral content
T4011 2181-2189 DiseaseOrPhenotypicFeature denotes fracture DISEASE
T80489 1966-1984 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T5 1881-1899 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T4 1782-1791 DiseaseOrPhenotypicFeature denotes fractures DISEASE
T36760 1153-1171 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T77210 957-975 DiseaseOrPhenotypicFeature denotes Hyperprolactinemia D006966
T25734 228-246 DiseaseOrPhenotypicFeature denotes hyperprolactinemia D006966
T75253 1867-1875 OrganismTaxon denotes patients
T50562 1755-1763 OrganismTaxon denotes patients
T79110 928-931 OrganismTaxon denotes ray

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 228-246 HP_0000870 denotes hyperprolactinemia

Allie

Id Subject Object Predicate Lexical cue
SS1_20331935_2_0 261-281 expanded denotes bone mineral density
SS2_20331935_2_0 283-286 abbr denotes BMD
SS1_20331935_13_0 1504-1543 expanded denotes selective serotonin reuptake inhibitors
SS2_20331935_13_0 1545-1550 abbr denotes SSRIs
AE1_20331935_2_0 SS1_20331935_2_0 SS2_20331935_2_0 abbreviatedTo bone mineral density,BMD
AE1_20331935_13_0 SS1_20331935_13_0 SS2_20331935_13_0 abbreviatedTo selective serotonin reuptake inhibitors,SSRIs

bc5cdr-valid-experiment

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 72-81 Chemical denotes serotonin
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 420-431 Chemical denotes risperidone
T6 957-975 Disease denotes Hyperprolactinemia
T7 1028-1039 Chemical denotes risperidone
T8 1071-1083 Chemical denotes testosterone
T9 1153-1171 Disease denotes hyperprolactinemia
T10 1514-1523 Chemical denotes serotonin
T11 1782-1791 Disease denotes fractures
T12 1810-1821 Chemical denotes risperidone
T13 1881-1899 Disease denotes hyperprolactinemia
T14 1946-1957 Chemical denotes risperidone
T15 1966-1984 Disease denotes hyperprolactinemia

bc5cdr-valid-deepseek-nr-ng

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 420-431 Chemical denotes risperidone
T6 1028-1039 Chemical denotes risperidone
T7 1153-1171 Disease denotes hyperprolactinemia
T8 1504-1543 Chemical denotes selective serotonin reuptake inhibitors

bc5cdr-valid-gemini-r-ng

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 957-975 Disease denotes Hyperprolactinemia
T6 1028-1039 Chemical denotes risperidone
T7 1071-1083 Chemical denotes testosterone
T8 1153-1171 Disease denotes hyperprolactinemia
T9 1504-1543 Chemical denotes selective serotonin reuptake inhibitors
T10 1545-1550 Chemical denotes SSRIs
T11 1782-1791 Disease denotes fractures

bc5cdr-valid

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 72-81 Chemical denotes serotonin
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 420-431 Chemical denotes risperidone
T6 957-975 Disease denotes Hyperprolactinemia
T7 1028-1039 Chemical denotes risperidone
T8 1071-1083 Chemical denotes testosterone
T9 1153-1171 Disease denotes hyperprolactinemia
T10 1514-1523 Chemical denotes serotonin
T11 1782-1791 Disease denotes fractures
T12 1810-1821 Chemical denotes risperidone
T13 1881-1899 Disease denotes hyperprolactinemia
T14 1946-1957 Chemical denotes risperidone
T15 1966-1984 Disease denotes hyperprolactinemia

bc5cdr-valid-gemini-r-g

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 420-431 Chemical denotes risperidone
T6 957-975 Disease denotes Hyperprolactinemia
T7 1028-1039 Chemical denotes risperidone
T8 1071-1083 Chemical denotes testosterone
T9 1153-1171 Disease denotes hyperprolactinemia
T10 1504-1543 Chemical denotes selective serotonin reuptake inhibitors
T11 1545-1550 Chemical denotes SSRIs
T12 1782-1791 Disease denotes fractures

bc5cdr-valid-gemini-nr-ng

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 420-431 Chemical denotes risperidone
T6 957-975 Disease denotes Hyperprolactinemia
T7 1028-1039 Chemical denotes risperidone
T8 1071-1083 Chemical denotes testosterone
T9 1153-1171 Disease denotes hyperprolactinemia
T10 1504-1543 Chemical denotes selective serotonin reuptake inhibitors
T11 1545-1550 Chemical denotes SSRIs
T12 1782-1791 Disease denotes fractures
T13 1810-1821 Chemical denotes risperidone
T14 1826-1830 Chemical denotes SSRI
T15 1881-1899 Disease denotes hyperprolactinemia

bc5cdr-valid-gemini-nr-g

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 105-125 Disease denotes bone mineral density
T4 208-219 Chemical denotes risperidone
T5 220-246 Disease denotes induced hyperprolactinemia
T6 250-281 Disease denotes trabecular bone mineral density
T7 283-286 Disease denotes BMD
T8 420-431 Chemical denotes risperidone
T9 870-873 Disease denotes BMD
T10 957-975 Disease denotes Hyperprolactinemia
T11 1028-1039 Chemical denotes risperidone
T12 1071-1083 Chemical denotes testosterone
T13 1153-1171 Disease denotes hyperprolactinemia
T14 1186-1206 Disease denotes bone mineral content
T15 1211-1214 Disease denotes BMD
T16 1375-1400 Disease denotes trabecular volumetric BMD
T17 1504-1543 Chemical denotes selective serotonin reuptake inhibitors
T18 1545-1550 Chemical denotes SSRIs
T19 1580-1594 Disease denotes trabecular BMD
T20 1782-1791 Disease denotes fractures
T21 1810-1821 Chemical denotes risperidone
T22 1958-1984 Disease denotes induced hyperprolactinemia
T23 2110-2123 Disease denotes adverse event
T24 2181-2194 Disease denotes fracture rate

bc5cdr-valid-gpt-nr-g

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 420-431 Chemical denotes risperidone
T6 957-975 Disease denotes Hyperprolactinemia
T7 1028-1039 Chemical denotes risperidone
T8 1071-1083 Chemical denotes testosterone
T9 1153-1171 Disease denotes hyperprolactinemia
T10 1504-1543 Chemical denotes selective serotonin reuptake inhibitors
T11 1545-1550 Chemical denotes SSRIs
T12 1782-1791 Disease denotes fractures
T13 1810-1821 Chemical denotes risperidone
T14 1826-1831 Chemical denotes SSRIs
T15 1881-1899 Disease denotes hyperprolactinemia
T16 1946-1957 Chemical denotes risperidone
T17 1966-1984 Disease denotes hyperprolactinemia
T18 2181-2189 Disease denotes fracture

bc5cdr-valid-gpt-r-g

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 420-431 Chemical denotes risperidone
T6 957-975 Disease denotes Hyperprolactinemia
T7 1028-1039 Chemical denotes risperidone
T8 1071-1083 Chemical denotes testosterone
T9 1153-1171 Disease denotes hyperprolactinemia
T10 1504-1543 Chemical denotes selective serotonin reuptake inhibitors
T11 1545-1550 Chemical denotes SSRIs
T12 1782-1791 Disease denotes fractures
T13 1810-1821 Chemical denotes risperidone
T14 1826-1831 Chemical denotes SSRIs
T15 1881-1899 Disease denotes hyperprolactinemia
T16 1946-1957 Chemical denotes risperidone
T17 1966-1984 Disease denotes hyperprolactinemia
T18 1989-1993 Chemical denotes SSRI
T19 2181-2189 Disease denotes fracture

bc5cdr-valid-deepseek-r-ng

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 420-431 Chemical denotes risperidone
T6 957-975 Disease denotes Hyperprolactinemia
T7 1071-1083 Chemical denotes testosterone
T8 1153-1171 Disease denotes hyperprolactinemia
T9 1545-1550 Chemical denotes SSRIs
T10 1782-1791 Disease denotes fractures

bc5cdr-valid-gpt-r-ng

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 420-431 Chemical denotes risperidone
T6 957-975 Disease denotes Hyperprolactinemia
T7 1028-1039 Chemical denotes risperidone
T8 1071-1083 Chemical denotes testosterone
T9 1153-1171 Disease denotes hyperprolactinemia
T10 1334-1343 Chemical denotes prolactin
T11 1504-1543 Chemical denotes selective serotonin reuptake inhibitors
T12 1545-1550 Chemical denotes SSRIs
T13 1782-1791 Disease denotes fractures
T14 1810-1821 Chemical denotes risperidone
T15 1826-1831 Chemical denotes SSRIs
T16 1881-1899 Disease denotes hyperprolactinemia
T17 1946-1957 Chemical denotes risperidone
T18 1966-1984 Disease denotes hyperprolactinemia
T19 1989-1993 Chemical denotes SSRI
T20 2181-2189 Disease denotes fracture

bc5cdr-valid-gpt-nr-ng

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 420-431 Chemical denotes risperidone
T6 957-975 Disease denotes Hyperprolactinemia
T7 1028-1039 Chemical denotes risperidone
T8 1071-1083 Chemical denotes testosterone
T9 1153-1171 Disease denotes hyperprolactinemia
T10 1334-1343 Chemical denotes prolactin
T11 1504-1543 Chemical denotes selective serotonin reuptake inhibitors
T12 1545-1550 Chemical denotes SSRIs
T13 1782-1791 Disease denotes fractures
T14 1810-1821 Chemical denotes risperidone
T15 1826-1831 Chemical denotes SSRIs
T16 1881-1899 Disease denotes hyperprolactinemia
T17 1946-1957 Chemical denotes risperidone
T18 1966-1984 Disease denotes hyperprolactinemia
T19 1989-1993 Chemical denotes SSRI
T20 2181-2189 Disease denotes fracture

bc5cdr-valid-gemini-r-m

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 420-431 Chemical denotes risperidone
T6 957-975 Disease denotes Hyperprolactinemia
T7 1028-1039 Chemical denotes risperidone
T8 1071-1083 Chemical denotes testosterone
T9 1153-1171 Disease denotes hyperprolactinemia
T10 1504-1543 Chemical denotes selective serotonin reuptake inhibitors
T11 1545-1550 Chemical denotes SSRIs
T12 1782-1791 Disease denotes fractures

bc5cdr-valid-gpt-r-m2

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 420-431 Chemical denotes risperidone
T6 957-975 Disease denotes Hyperprolactinemia
T7 1028-1039 Chemical denotes risperidone
T8 1071-1083 Chemical denotes testosterone
T9 1153-1171 Disease denotes hyperprolactinemia
T10 1504-1543 Chemical denotes selective serotonin reuptake inhibitors
T11 1545-1550 Chemical denotes SSRIs
T12 1782-1791 Disease denotes fractures
T13 1810-1821 Chemical denotes risperidone
T14 1826-1831 Chemical denotes SSRIs
T15 1881-1899 Disease denotes hyperprolactinemia
T16 1946-1957 Chemical denotes risperidone
T17 1966-1984 Disease denotes hyperprolactinemia
T18 1989-1993 Chemical denotes SSRI
T19 2181-2189 Disease denotes fracture

bc5cdr-valid-deepseek-r-g

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 420-431 Chemical denotes risperidone
T6 957-975 Disease denotes Hyperprolactinemia
T7 1028-1039 Chemical denotes risperidone
T8 1071-1083 Chemical denotes testosterone
T9 1153-1171 Disease denotes hyperprolactinemia
T10 1545-1550 Chemical denotes SSRIs
T11 1782-1791 Disease denotes fractures

bc5cdr-valid-deepseek-nr-g

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 1028-1039 Chemical denotes risperidone
T6 1153-1171 Disease denotes hyperprolactinemia
T7 1504-1543 Chemical denotes selective serotonin reuptake inhibitors
T8 1545-1549 Chemical denotes SSRI
T9 1782-1791 Disease denotes fractures

bc5cdr-valid-deepseek-r-m

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 420-431 Chemical denotes risperidone
T6 957-975 Disease denotes Hyperprolactinemia
T7 1028-1039 Chemical denotes risperidone
T8 1071-1083 Chemical denotes testosterone
T9 1153-1171 Disease denotes hyperprolactinemia
T10 1545-1550 Chemical denotes SSRIs
T11 1782-1791 Disease denotes fractures

bc5cdr-valid-gpt-r-m

Id Subject Object Predicate Lexical cue
T1 46-57 Chemical denotes risperidone
T2 62-101 Chemical denotes selective serotonin reuptake inhibitors
T3 208-219 Chemical denotes risperidone
T4 228-246 Disease denotes hyperprolactinemia
T5 420-431 Chemical denotes risperidone
T6 957-975 Disease denotes Hyperprolactinemia
T7 1028-1039 Chemical denotes risperidone
T8 1071-1083 Chemical denotes testosterone
T9 1153-1171 Disease denotes hyperprolactinemia
T10 1504-1543 Chemical denotes selective serotonin reuptake inhibitors
T11 1545-1550 Chemical denotes SSRIs
T12 1782-1791 Disease denotes fractures
T13 1810-1821 Chemical denotes risperidone
T14 1826-1831 Chemical denotes SSRIs
T15 1881-1899 Disease denotes hyperprolactinemia
T16 1946-1957 Chemical denotes risperidone
T17 1966-1984 Disease denotes hyperprolactinemia
T18 1989-1993 Chemical denotes SSRI